| RS2151544901 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151544918 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151545014 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151545035 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151545272 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151549200 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2151549469 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS2151549770 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151549840 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2151550125 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Hypoplastic aortic arch |
| RS2151550210 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151550241 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550259 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151550270 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550327 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550384 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550494 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550502 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550507 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550685 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550700 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550703 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151550708 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151550785 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151551059 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151551135 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151551960 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151553190 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151553250 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151553285 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151553286 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151553312 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151553456 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151553540 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151553635 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151554076 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151554391 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, Neurofibromatosis |
| RS2151554438 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554452 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554507 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554602 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554607 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554842 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554894 |
NF1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151554927 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554936 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151554939 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151555120 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151555200 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151555210 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151555896 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151555987 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556054 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556088 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151556101 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556124 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151556143 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556162 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556165 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556220 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151556280 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151556290 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151556401 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556446 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556452 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556490 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556491 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556510 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556540 |
NF1
|
Health Risk |
Pathogenic |
Gastric cancer, Neurofibromatosis |
| RS2151556621 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556776 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151556799 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2151557324 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151557367 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151557372 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2151557411 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151557496 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151557502 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151557558 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558070 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558071 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558108 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558122 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558160 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151558358 |
PRMT7
|
Health Risk |
Likely pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS2151559073 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559183 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559206 |
PRMT7
|
Health Risk |
Likely pathogenic |
— |
| RS2151559216 |
NF1
|
Health Risk |
Pathogenic |
Neurofibroma, Neurofibromatosis |
| RS2151559233 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151559288 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559296 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559362 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559369 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151559384 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151561113 |
CHD3
|
Health Risk |
Likely pathogenic |
— |
| RS2151561390 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151561453 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151561461 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2151561465 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |